In CRC, a greater proportion of CD25+FoxP3+ TI Tregs expressed Ki67, compared with Tregs from tumor-free liver and peripheral blood, indicating efficient in situ proliferation [42]. This evidence concerns the gene FOXP3 and neoplasm.